Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sorrento Therapeutics Inc (NASDAQ:SRNE)

2.08
Delayed Data
As of 2:49pm ET
 -0.025 / -1.19%
Today’s Change
1.50
Today|||52-Week Range
8.35
-57.65%
Year-to-Date
No recent news for Sorrento Therapeutics Inc.

Today’s Trading

Previous close2.10
Today’s open2.10
Day’s range2.05 - 2.10
Volume204,590
Average volume (3 months)1,044,378
Market cap$160.7M
Dividend yield--
Data as of 2:49pm ET, 07/25/2017

Growth & Valuation

Earnings growth (last year)+2.42%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+77.60%
P/E ratioNM
Price/Sales30.27
Price/Book1.14

Competitors

 Today’s
change
Today’s
% change
VRNAVerona Pharma PLC+0.05+0.41%
SMMTSummit Therapeutics ...+0.26+2.04%
MDWDMediwound Ltd+0.10+1.41%
ACRXAcelRx Pharmaceutica...+0.05+1.37%
Data as of 3:01pm ET, 07/25/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$8.2M
Annual profit (last year)-$60.9M
Net profit margin-747.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Henry H. Ji
Chief Financial Officer &
Executive Vice President
Kevin M. Herde
Corporate headquarters
San Diego, California

Forecasts